The deaths of a man and a woman in Northern Ireland were reported to the UK’s drug watchdog due to fears they were linked to weight-loss drugs, a report has revealed.
The Medicine and Healthcare Regulatory Agency (MHRA) received reports of the deaths in 2024 and 2025. They were two of more than 500 adverse drug reaction reports submitted from Northern Ireland during that time, which were suspected to be tied to GLP-1 medications.
